New Year Bumper Sale @ Rs. 1 X
Olmetrack CT 20 Mg/12.5 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Olmetrack CT 20 Mg/12.5 Mg Tablet have also been explained below.
The right dosage of Olmetrack CT 20 Mg/12.5 Mg Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Olmetrack CT 20 Mg/12.5 Mg Tablet also has some side effects, the most common being Headache, Nausea or vomiting, Diarrhoea. Such side effects of Olmetrack CT 20 Mg/12.5 Mg Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Olmetrack CT 20 Mg/12.5 Mg Tablet is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Olmetrack CT 20 Mg/12.5 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmetrack CT 20 Mg/12.5 Mg Tablet related warnings section.
Olmetrack CT 20 Mg/12.5 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Liver Disease are examples of such conditions.
Drug reaction of Olmetrack CT 20 Mg/12.5 Mg Tablet with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Olmetrack CT 20 Mg/12.5 Mg Tablet is considered not safe while driving, and is not addictive.
Olmetrack CT 20 Mg/12.5 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Olmetrack CT 20 Mg/12.5 Mg Tablet safe for pregnant women?
Olmetrack CT shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Olmetrack CT 20 Mg/12.5 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Olmetrack CT. So it is adviced to consult the doctor before using it.
What is the effect of Olmetrack CT 20 Mg/12.5 Mg Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Olmetrack CT. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Olmetrack CT 20 Mg/12.5 Mg Tablet on the Liver?
The liver can be affected by Olmetrack CT. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Olmetrack CT only after medical advice.
What is the effect of Olmetrack CT 20 Mg/12.5 Mg Tablet on the Heart?
Olmetrack CT may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Olmetrack CT 20 Mg/12.5 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Olmetrack CT 20 Mg/12.5 Mg Tablet unless your doctor advises you to do so -
Is this Olmetrack CT 20 Mg/12.5 Mg Tablet habit forming or addictive?
No, you will not get addicted to Olmetrack CT 20 Mg/12.5 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
After taking Olmetrack CT 20 Mg/12.5 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Olmetrack CT 20 Mg/12.5 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Olmetrack CT 20 Mg/12.5 Mg Tablet for mental disorders.
Interaction between Food and Olmetrack CT 20 Mg/12.5 Mg Tablet
There isn't any research available on the side effects of taking Olmetrack CT 20 Mg/12.5 Mg Tablet with food.
Interaction between Alcohol and Olmetrack CT 20 Mg/12.5 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Olmetrack CT 20 Mg/12.5 Mg Tablet with alcohol will be.
No, Olmetrack CT is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take this medicine without a doctor's recommendation because it can cause very unpleasant side effects. Hence, the patient should seek doctors advice before taking this medication by himself or herself.
Olmetrack CT works by increasing the rate of urine formation by inhibiting the sodium and potassium reabsorption in the kidney, this causes more frequent urination than normal. The increased flow of urination leads to a decrease in blood volume that helps in the relaxation of the walls of blood vessels and this results in a decrease in blood pressure.
Yes, Olmetrack CT may cause itching or rashes but it occurs rarely. If you experience excessive rashes or itching then consult it with your doctor without any further delay.
Yes, Olmetrack CT may cause hair loss. If you are experiencing severe hair loss after taking this drug, you are advised to consult it with your doctor.
Yes, you may feel dizzy after taking [Medicine. It has been reported by the patients who are taking this drug. If you are experiencing the same after taking this drug, you are advised to consult about it with your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173